{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:19:43Z","timestamp":1788884383193,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012411","name":"Alborz University of Medical Sciences","doi-asserted-by":"publisher","award":["99-4205"],"award-info":[{"award-number":["99-4205"]}],"id":[{"id":"10.13039\/501100012411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.prp.2022.154139","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T11:26:21Z","timestamp":1663586781000},"page":"154139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Restoration of miR-648 overcomes 5-FU-resistance through targeting ET-1 in gastric cancer cells in-vitro"],"prefix":"10.1016","volume":"239","author":[{"given":"Parsa","family":"Aliabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Sadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goli","family":"Siri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnoosh","family":"Ebrahimzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalda","family":"Yazdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem Maximovich","family":"Gusarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar Afzali","family":"Kharkouei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Adili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Mardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.prp.2022.154139_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.prp.2022.154139_bib2","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.3748\/wjg.v22.i8.2403","article-title":"Advanced gastric cancer: current treatment landscape and future perspectives","volume":"22","author":"Digklia","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.prp.2022.154139_bib3","first-page":"13657","article-title":"Surgical interventions for gastric cancer: a review of systematic reviews","volume":"8","author":"He","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"8","key":"10.1016\/j.prp.2022.154139_bib4","article-title":"Chemotherapy for advanced gastric cancer","volume":"8","author":"Wagner","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"8","key":"10.1016\/j.prp.2022.154139_bib5","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1634\/theoncologist.2019-0330","article-title":"Docetaxel, oxaliplatin, and 5-fluorouracil (DOF) in metastatic and unresectable gastric\/gastroesophageal junction adenocarcinoma: A phase II study with long-term follow-up","volume":"24","author":"Rosenberg","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.prp.2022.154139_bib6","doi-asserted-by":"crossref","unstructured":"H. Li, C. Wang, L. Lan, W. Wu, I. Evans, E.J. Ruiz, et al., Oxaliplatin Compromised CDK1 Activity Sensitizes BRCA-Proficient Cancers to PARP Inhibition in Oxaliplatin Resistance Gastric Cancer, 2021.","DOI":"10.21203\/rs.3.rs-529788\/v1"},{"issue":"3","key":"10.1016\/j.prp.2022.154139_bib7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/cvr\/cvp310","article-title":"Endothelin signalling in arterial smooth muscle is tightly regulated by G protein-coupled receptor kinase 2","volume":"85","author":"Morris","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.prp.2022.154139_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/jpm10040199","article-title":"Dysregulation of endothelin-1: implications for health disparities in Alzheimer's disease","volume":"10","author":"Alcendor","year":"2020","journal-title":"J. Pers. Med."},{"issue":"2","key":"10.1016\/j.prp.2022.154139_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semnephrol.2015.02.002","article-title":"Endothelin receptors and their antagonists","volume":"35","author":"Maguire","year":"2015","journal-title":"Semin. Nephrol."},{"issue":"4","key":"10.1016\/j.prp.2022.154139_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1152\/japplphysiol.00641.2015","article-title":"Endothelin-1 mediates intermittent hypoxia-induced inflammatory vascular remodeling through HIF-1 activation","volume":"120","author":"Gras","year":"2016","journal-title":"J. Appl. Physiol."},{"issue":"9","key":"10.1016\/j.prp.2022.154139_bib11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrc3546","article-title":"Endothelin 1 in cancer: biological implications and therapeutic opportunities","volume":"13","author":"Rosan\u00f2","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"30","key":"10.1016\/j.prp.2022.154139_bib12","doi-asserted-by":"crossref","first-page":"10432","DOI":"10.3748\/wjg.v20.i30.10432","article-title":"MiRNA as potential biomarkers and therapeutic targets for gastric cancer","volume":"20","author":"Shin","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.prp.2022.154139_bib13","first-page":"1273","article-title":"MicroRNA dysregulation in gastric cancer","volume":"19","author":"Pan","year":"2013","journal-title":"Curr. Pharmaceut. Des."},{"issue":"1","key":"10.1016\/j.prp.2022.154139_bib14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3892\/or.2014.3598","article-title":"Emerging role of microRNAs in modulating endothelin-1 expression in gastric cancer","volume":"33","author":"Tsai","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2022.154139_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107355","article-title":"miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and oxaliplatin chemoresistance by targeting CXCR4","volume":"92","author":"Azar","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"7 Pt 1","key":"10.1016\/j.prp.2022.154139_bib16","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1158\/1078-0432.CCR-05-1853","article-title":"Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer","volume":"12","author":"Xi","year":"2006","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"5","key":"10.1016\/j.prp.2022.154139_bib17","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2022.154139_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","article-title":"microRNAs as oncogenes and tumor suppressors","volume":"302","author":"Zhang","year":"2007","journal-title":"Dev. Biol."},{"issue":"3","key":"10.1016\/j.prp.2022.154139_bib19","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1124\/pr.119.019026","article-title":"Strategies to modulate microRNA functions for the treatment of cancer or organ injury","volume":"72","author":"Lee","year":"2020","journal-title":"Pharm. Rev."},{"issue":"6","key":"10.1016\/j.prp.2022.154139_bib20","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.3892\/etm.2017.4314","article-title":"Functions of endothelin-1 in apoptosis and migration in hepatocellular carcinoma","volume":"13","author":"Shi","year":"2017","journal-title":"Exp. Ther. Med."},{"issue":"16","key":"10.1016\/j.prp.2022.154139_bib21","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1002\/cam4.2560","article-title":"Ovarian cancer: current status and strategies for improving therapeutic outcomes","volume":"8","author":"Chandra","year":"2019","journal-title":"Cancer Med."},{"issue":"2","key":"10.1016\/j.prp.2022.154139_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/or.2021.8122","article-title":"Endothelin-1 induces changes in the expression levels of steroidogenic enzymes and increases androgen receptor and testosterone production in the PC3 prostate cancer cell line","volume":"46","author":"Torres","year":"2021","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.prp.2022.154139_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/bjs.5536","article-title":"Mechanisms of endothelin 1-stimulated proliferation in colorectal cancer cell lines","volume":"94","author":"Grant","year":"2007","journal-title":"Br. J. Surg."},{"issue":"10","key":"10.1016\/j.prp.2022.154139_bib24","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1038\/cdd.2017.121","article-title":"Blocking endothelin-1-receptor\/\u03b2-catenin circuit sensitizes to chemotherapy in colorectal cancer","volume":"24","author":"Cianfrocca","year":"2017","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.prp.2022.154139_bib25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5152\/eurasianjmed.2020.20033","article-title":"Role of endothelin 1 on proliferation and migration of human MCF-7 cells","volume":"52","author":"Cinar","year":"2020","journal-title":"Eurasia J. Med."},{"issue":"6","key":"10.1016\/j.prp.2022.154139_bib26","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1007\/s13277-015-3118-7","article-title":"Endothelin-1 overexpression: a potential biomarker of unfavorable prognosis in non-metastatic muscle-invasive bladder cancer","volume":"36","author":"Mitrakas","year":"2015","journal-title":"Tumour Biol.: J. Int. Soc. Oncodev. Biol. Med."},{"issue":"6","key":"10.1016\/j.prp.2022.154139_bib27","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.3892\/ol.2017.6027","article-title":"Effects of silencing endothelin-1 on invasion and vascular formation in lung cancer","volume":"13","author":"Zhang","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2022.154139_bib28","first-page":"3","article-title":"Endocan, ET-1, and ETAR expression profiles in unicystic ameloblastoma, multicystic ameloblastoma, and ameloblastic carcinoma","volume":"10","author":"Irani","year":"2019","journal-title":"Middle East J. Cancer"},{"issue":"8","key":"10.1016\/j.prp.2022.154139_bib29","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1158\/0008-5472.CAN-06-3879","article-title":"In vitro and in vivo molecular evidence for better therapeutic efficacy of ABT-627 and taxotere combination in prostate cancer","volume":"67","author":"Banerjee","year":"2007","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.prp.2022.154139_bib30","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0026-895X(24)12115-3","article-title":"Endothelin-1 protects ovarian carcinoma cells against paclitaxel-induced apoptosis: requirement for Akt activation","volume":"61","author":"Del Bufalo","year":"2002","journal-title":"Mol. Pharm."},{"issue":"3b","key":"10.1016\/j.prp.2022.154139_bib31","first-page":"2503","article-title":"Pre- and post-operative plasma big endothelin-1 levels in patients with gastric carcinoma undergoing radical gastrectomy","volume":"26","author":"Teng","year":"2006","journal-title":"Anticancer Res."},{"issue":"11\u201312","key":"10.1016\/j.prp.2022.154139_bib32","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.lfs.2012.08.015","article-title":"MicroRNA-1 inhibits proliferation of hepatocarcinoma cells by targeting endothelin-1","volume":"91","author":"Li","year":"2012","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.prp.2022.154139_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13048-019-0513-5","article-title":"Association of miRNA -\u2009320 expression level and its target gene endothelin-1 with the susceptibility and clinical features of polycystic ovary syndrome","volume":"12","author":"Rashad","year":"2019","journal-title":"J. Ovarian Res."},{"issue":"1","key":"10.1016\/j.prp.2022.154139_bib34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10120-017-0721-x","article-title":"MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer","volume":"21","author":"Xie","year":"2018","journal-title":"Gastric Cancer: Off. J. Int. Gastric Cancer Assoc. Jpn. Gastric Cancer Assoc."},{"issue":"4","key":"10.1016\/j.prp.2022.154139_bib35","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.18632\/oncotarget.6546","article-title":"miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma","volume":"7","author":"Sestito","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2022.154139_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1755-8794-4-79","article-title":"miRNA signature associated with outcome of gastric cancer patients following chemotherapy","volume":"4","author":"Kim","year":"2011","journal-title":"BMC Med. Genom."},{"issue":"1","key":"10.1016\/j.prp.2022.154139_bib37","doi-asserted-by":"crossref","first-page":"538","DOI":"10.18632\/oncotarget.6374","article-title":"The miR27b-CCNG1-P53-miR-508-5p axis regulates multidrug resistance of gastric cancer","volume":"7","author":"Shang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2022.154139_bib38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.abb.2019.01.023","article-title":"MicroRNA-31 triggers G(2)\/M cell cycle arrest, enhances the chemosensitivity and inhibits migration and invasion of human gastric cancer cells by downregulating the expression of zeste homolog 2 (ZH2)","volume":"663","author":"Sun","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"issue":"18","key":"10.1016\/j.prp.2022.154139_bib39","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1177\/1535370217728460","article-title":"MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells","volume":"242","author":"Korourian","year":"2017","journal-title":"Exp. Biol. Med."},{"issue":"1","key":"10.1016\/j.prp.2022.154139_bib40","first-page":"35","article-title":"Induction of miR-31 causes increased sensitivity to 5-FU and decreased migration and cell invasion in gastric adenocarcinoma","volume":"120","author":"Korourian","year":"2019","journal-title":"Bratisl. Lek. Listy"},{"issue":"1\u20132","key":"10.1016\/j.prp.2022.154139_bib41","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11010-014-2028-0","article-title":"MicroRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer","volume":"392","author":"Xie","year":"2014","journal-title":"Mol. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.prp.2022.154139_bib42","first-page":"1370","article-title":"miR\u2011195\u20135p regulates multi\u2011drug resistance of gastric cancer cells via targeting ZNF139","volume":"40","author":"Nie","year":"2018","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.prp.2022.154139_bib43","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.3892\/mmr.2015.4052","article-title":"MicroRNA\u2011197 reverses the drug resistance of fluorouracil\u2011induced SGC7901 cells by targeting mitogen\u2011activated protein kinase 1","volume":"12","author":"Xiong","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.prp.2022.154139_bib44","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1159\/000490871","article-title":"Sensitization of gastric cancer cells to 5-FU by microRNA-204 through targeting the TGFBR2-mediated epithelial to mesenchymal transition","volume":"47","author":"Li","year":"2018","journal-title":"Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol., Biochem. Pharm."},{"issue":"4","key":"10.1016\/j.prp.2022.154139_bib45","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1159\/000438524","article-title":"MiR-429 induces gastric carcinoma cell apoptosis through Bcl-2","volume":"37","author":"Zhu","year":"2015","journal-title":"Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol. Biochem. Pharm."},{"issue":"25","key":"10.1016\/j.prp.2022.154139_bib46","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1038\/onc.2013.297","article-title":"miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1","volume":"33","author":"Shang","year":"2014","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.prp.2022.154139_bib47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3727\/096504018X15193469240508","article-title":"MicroRNA-623 targets cyclin D1 to inhibit cell proliferation and enhance the chemosensitivity of cells to 5-fluorouracil in gastric cancer","volume":"27","author":"Jiang","year":"2018","journal-title":"Oncol. Res."},{"issue":"1","key":"10.1016\/j.prp.2022.154139_bib48","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12943-017-0586-y","article-title":"Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf\/MEK\/ERK pathway","volume":"16","author":"Zhang","year":"2017","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.prp.2022.154139_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143716","article-title":"Overexpression of Lin28 decreases the chemosensitivity of gastric cancer cells to oxaliplatin, paclitaxel, doxorubicin, and fluorouracil in part via microRNA-107","volume":"10","author":"Teng","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.prp.2022.154139_bib50","first-page":"6397","article-title":"MiR-218 inhibits multidrug resistance (MDR) of gastric cancer cells by targeting Hedgehog\/smoothened","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"2","key":"10.1016\/j.prp.2022.154139_bib51","doi-asserted-by":"crossref","first-page":"504","DOI":"10.5114\/aoms.2017.69374","article-title":"MiR-21, miR-34a, miR-125b, miR-181d and miR-648 levels inversely correlate with MGMT and TP53 expression in primary glioblastoma patients","volume":"15","author":"Jesionek-Kupnicka","year":"2019","journal-title":"Arch. Med. Sci.: AMS"},{"issue":"5","key":"10.1016\/j.prp.2022.154139_bib52","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00401-013-1081-1","article-title":"In human glioblastomas transcript elongation by alternative polyadenylation and miRNA targeting is a potent mechanism of MGMT silencing","volume":"125","author":"Kreth","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.prp.2022.154139_bib53","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1128\/MCB.01199-14","article-title":"MicroRNA 648 targets ET-1 mRNA and is cotranscriptionally regulated with MICAL3 by PAX5","volume":"35","author":"Li","year":"2015","journal-title":"Mol. Cell. Biol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822003831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822003831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:53:39Z","timestamp":1759733619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033822003831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":53,"alternative-id":["S0344033822003831"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2022.154139","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Restoration of miR-648 overcomes 5-FU-resistance through targeting ET-1 in gastric cancer cells in-vitro","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2022.154139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154139"}}